JP2023540444A5 - - Google Patents
Info
- Publication number
- JP2023540444A5 JP2023540444A5 JP2023507798A JP2023507798A JP2023540444A5 JP 2023540444 A5 JP2023540444 A5 JP 2023540444A5 JP 2023507798 A JP2023507798 A JP 2023507798A JP 2023507798 A JP2023507798 A JP 2023507798A JP 2023540444 A5 JP2023540444 A5 JP 2023540444A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- cdr
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2012331.1A GB202012331D0 (en) | 2020-08-07 | 2020-08-07 | Therapeutic antibodies |
| GB2012331.1 | 2020-08-07 | ||
| PCT/GB2021/052043 WO2022029447A1 (en) | 2020-08-07 | 2021-08-06 | Therapeutic antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540444A JP2023540444A (ja) | 2023-09-25 |
| JP2023540444A5 true JP2023540444A5 (enExample) | 2026-02-02 |
Family
ID=72520053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507798A Pending JP2023540444A (ja) | 2020-08-07 | 2021-08-06 | 治療用抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230272097A1 (enExample) |
| EP (1) | EP4192867A1 (enExample) |
| JP (1) | JP2023540444A (enExample) |
| CN (1) | CN116249710A (enExample) |
| AU (1) | AU2021319941A1 (enExample) |
| CA (1) | CA3186391A1 (enExample) |
| GB (1) | GB202012331D0 (enExample) |
| WO (1) | WO2022029447A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240052871A (ko) | 2016-04-27 | 2024-04-23 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| US20220332837A1 (en) * | 2021-04-08 | 2022-10-20 | Colorado State University Research Foundation | Methods and compositions for ox40 activation in treatment of canine cancer |
| IL314314A (en) * | 2022-02-09 | 2024-09-01 | Petmedix Ltd | Therapeutic antibodies |
| GB202217978D0 (en) * | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
| AU2023417626A1 (en) | 2022-12-27 | 2025-07-10 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| WO2024155982A2 (en) | 2023-01-20 | 2024-07-25 | Invetx, Inc. | Bispecific binding agents for use in companion animals |
| WO2025174998A1 (en) * | 2024-02-13 | 2025-08-21 | Invetx, Inc. | Anti-il-31ra antibodies and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| AU2005229009A1 (en) * | 2004-03-23 | 2005-10-13 | Amgen, Inc. | Monoclonal antibodies specific for human OX40L (CD 134L) |
| GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
| US7812133B2 (en) * | 2005-12-16 | 2010-10-12 | Genentech, Inc | Anti-OX40L antibodies and methods using same |
| HRP20180858T1 (hr) | 2011-07-11 | 2018-09-21 | Glenmark Pharmaceuticals S.A. | Protutijela koja se vežu na ox40 i njihove uporabe |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| AU2013221502C1 (en) * | 2012-02-14 | 2018-03-01 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom |
| GB201316644D0 (en) | 2013-09-19 | 2013-11-06 | Kymab Ltd | Expression vector production & High-Throughput cell screening |
| US10196435B2 (en) | 2013-11-18 | 2019-02-05 | University Of Southern California | OX40L fusion protein for the immunotherapy of tumors of veterinary animals |
| KR102740384B1 (ko) | 2015-03-03 | 2024-12-06 | 키맵 리미티드 | 항체, 용도 및 방법 |
| GB2561352B (en) | 2017-04-10 | 2023-01-18 | Genome Res Ltd | Animal models and therapeutic molecules |
| KR20250026872A (ko) | 2018-03-16 | 2025-02-25 | 조에티스 서비시즈 엘엘씨 | 수의학적 용도를 위한 인터류킨-31 단클론성 항체 |
| GB2578867A (en) | 2018-10-09 | 2020-06-03 | Genome Res Ltd | Animal models and therapeutic molecules |
-
2020
- 2020-08-07 GB GBGB2012331.1A patent/GB202012331D0/en not_active Ceased
-
2021
- 2021-08-06 EP EP21758732.8A patent/EP4192867A1/en active Pending
- 2021-08-06 CA CA3186391A patent/CA3186391A1/en active Pending
- 2021-08-06 CN CN202180058009.6A patent/CN116249710A/zh active Pending
- 2021-08-06 JP JP2023507798A patent/JP2023540444A/ja active Pending
- 2021-08-06 WO PCT/GB2021/052043 patent/WO2022029447A1/en not_active Ceased
- 2021-08-06 US US18/007,314 patent/US20230272097A1/en active Pending
- 2021-08-06 AU AU2021319941A patent/AU2021319941A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250122301A1 (en) | Cd25 antibodies | |
| RU2474588C2 (ru) | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения | |
| Willems et al. | Rituximab therapy for childhood-onset systemic lupus erythematosus | |
| US10479830B2 (en) | Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines | |
| HUE034282T2 (en) | A monoclonal antibody to dog interleukin-31 | |
| RU2014121043A (ru) | Биспецифические иммуносвязывающие средства, направленные против tnf и il-17 | |
| CN109384844B (zh) | 一种抗金黄色葡萄球菌α溶血素单克隆抗体及应用 | |
| JP2017513813A5 (enExample) | ||
| WO2009140348A4 (en) | Anti-il-6/il-6r antibodies and methods of use thereof | |
| JP2023540444A (ja) | 治療用抗体 | |
| JP2017525655A5 (enExample) | ||
| WO2022117079A1 (zh) | 结合胸腺基质淋巴细胞生成素的抗体及其应用 | |
| JP2022527646A5 (enExample) | ||
| WO2005114218B1 (en) | Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule | |
| JP2025506488A5 (enExample) | ||
| Hu et al. | Potential therapeutic strategies in chronic inflammatory demyelinating polyradiculoneuropathy | |
| RU2024121576A (ru) | Терапевтические антитела | |
| US20240360210A1 (en) | Use of an il-18 antagonist for treating and/or prevention of atopic dermatitis or a related condition | |
| KR20230154239A (ko) | 항체-매개 이식 거부의 치료에 사용하기 위한 항-cd38 항체 | |
| CN118715244A (zh) | 治疗性抗体 | |
| JP2025506488A (ja) | 治療抗体 | |
| CN104391114B (zh) | Elisa方法定量测定人血清中重组人鼠嵌合抗cd20单克隆抗体浓度 | |
| RU2795411C2 (ru) | Моноклональные антитела к интерлейкину-31 для ветеринарного применения | |
| HK40063825A (en) | Cd25 antibodies | |
| NZ773527B2 (en) | Antibodies, uses & methods |